Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03456921 · ClinicalTrials.gov registry record · NA
Using an End-of-life Conversation Game to Engage Underserved Communities in Advance Care Planning
A NA study, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 1,122
- Enrollment target
NCT03456921: Completed NA study, sponsored by Milton S. Hershey Medical Center.
NCT03456921 is a NA study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 1,122 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (20% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03456921, a NA study, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,122 participants
- Enrollment target
Study Summary
This national project will provide an effective, evidence-based intervention for advance care planning (ACP) to 50 underserved US communities, those with poor access to healthcare systems due to economic, cultural or other barriers. The project will also examine 15 of the 50 communities to learn about the unique needs of African American communities in regards to ACP and to assess the intervention with this population. The team includes the Hospice Foundation of America and a university-based research team from Penn State Milton S. Hershey Medical Center.
Primary Outcome
This phone questionnaire assesses whether participants went on to perform various behaviors related to advance care planning.
Interventions
- OTHER End-of-life conversation game called "Hello"
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,122 participants |
| Start Date | 2018-02-28 |
| Est. Completion | 2019-09-15 |
| Phase | NA |
What the finished NCT03456921 record still lists
NCT03456921 is an interventional study that assigns participants to a tested intervention. Its 1,122 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (20% lower).
The record links to 0 conditions, and to 1 intervention - of which End-of-life conversation game called "Hello" is the first listed.
NCT03456921 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03456921 about?
NCT03456921 is a clinical study titled "Using an End-of-life Conversation Game to Engage Underserved Communities in Advance Care Planning". This national project will provide an effective, evidence-based intervention for advance care planning (ACP) to 50 underserved US communities, those with poor access to healthcare systems due to economic, cultural or other barriers. The project will also examine 15 of the 50 communities to learn abo...
What is the current status of trial NCT03456921?
This trial is currently completed. It is a NA study. The enrollment target is 1,122 participants. The study started on 2018-02-28. Estimated completion is 2019-09-15.
What interventions are being tested in trial NCT03456921?
The interventions under investigation include: End-of-life conversation game called "Hello" (OTHER).
Who is sponsoring clinical trial NCT03456921?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03456921's enrollment target sits among peer trials
1,122 93rd of 2000 higher than 1,908 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05691478 · 1,122 participants · Phase 2
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
- NCT05438329 · 1,123 participants · Phase 1
First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors
- NCT06952504 · 1,123 participants · Phase 3
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- NCT02140255 · 1,120 participants · Phase 1
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI